FIVE PRIME THERAPEUTICS, INC. SEC Filings

Filed On	Filing
15 Feb 2022	SC 13G/A
17 May 2021	SC 13G/A
26 Apr 2021	15-12B
21 Apr 2021	EFFECT
19 Apr 2021	Form 4: Sarena Francis Willard, Chief Strategy Officer Gave 3,825 shares as a gift · Acquired 2,385 shares (Gift) · Gave 2,460 shares as a gift · 4 more
19 Apr 2021	Form 4: Smith David V, Executive Vice President & CFO Received 66,000 shares as a grant or award · Returned 138,947 shares to the issuer ($5.28M) · Disposed of 365,000 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Collins Helen Louise, EVP and Chief Medical Officer Gave 8,085 shares as a gift · Received 66,000 shares as a grant or award · Returned 135,547 shares to the issuer ($5.15M) · 1 more
19 Apr 2021	Form 4: White David, See Remarks Returned 33,423 shares to the issuer ($1.27M) · Disposed of 55,000 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Ringo William R, Director Gave 10,000 shares as a gift · Disposed of 64,100 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 340,352 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Berger Franklin M, Director Returned 5,000 shares to the issuer ($190K) · Disposed of 67,500 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Dhingra Kapil, Director Disposed of 80,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Jensen Peder, Director Disposed of 80,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Nicholson Garry A, Director Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Schafer Carol, Director Disposed of 46,250 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Lyons-Williams Lori, Director Disposed of 45,000 Stock Option (right to buy) (Disposition to Issuer)
19 Apr 2021	Form 4: Civik Thomas, Director Returned 68,971 shares to the issuer ($2.62M) · Disposed of 480,000 Employee Stock Option (right to buy) (Disposition to Issuer)
16 Apr 2021	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
16 Apr 2021	S-8 POS
16 Apr 2021	S-8 POS
16 Apr 2021	S-8 POS

Comments